Cytochrome P450 4A and 2E1 expression in human kidney microsomes

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Cytochrome P450 enzymes (CYP) play crucial roles in xenobiotic and endogenous compound metabolism.
• Fatty acid omega- and (omega-1)-hydroxylation are important metabolic pathways.
• Previous studies suggested varying CYP expression and activity across human tissues.

Purpose of the Study:

• To investigate the presence and activity of cytochrome P450 2E1 (CYP2E1) and CYP4A in human kidney microsomes.
• To characterize the omega- and (omega-1)-hydroxylase activities of laurate and arachidonate in human kidney.
• To determine the contribution of CYP4A and CYP2E1 to these hydroxylase activities in the human kidney.

Main Methods:

• Measurement of laurate and arachidonate omega- and (omega-1)-hydroxylase activities in 18 human kidney microsomal samples.
• Immunoblot analysis to detect CYP4A and CYP2E1 content.
• Enzyme inhibition studies using specific polyclonal antibodies against CYP2E1 and CYP4A1.

Main Results:

• Human kidney microsomes showed significantly different laurate and arachidonate hydroxylation rates compared to liver, with a high laurate omega/omega-1 ratio (approx. 22).
• CYP4A was detected in human kidney microsomes, while CYP2E1 was not detectable, contrary to findings in liver.
• Laurate and arachidonate omega-hydroxylase activities strongly correlated with CYP4A content and were significantly inhibited by anti-CYP4A1 antibody, but not by anti-CYP2E1 antibody.

Conclusions:

• Human kidney microsomes possess significant CYP4A and fatty acid omega-hydroxylase activity.
• Unlike other species, human kidney microsomes do not appear to contain significant amounts of CYP2E1.
• CYP4A is the primary enzyme responsible for fatty acid omega-hydroxylation in the human kidney.